Design of immunogens that present the crown of the HIV-1V3 loop in a conformation competent to generate 447-52D-like antibodies

被引:22
作者
Chakraborty, Kausik
Durani, Venuka
Miranda, Edward Roshan
Citron, Michael
Liang, Xiaoping
Schleif, William
Joyce, Joseph G. [1 ]
Varadarajan, Raghavan
机构
[1] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India
[2] Merck Res Labs, West Point, PA 19486 USA
[3] Jawaharlal Nehru Ctr Adv Sci Res, Chem Biol Unit, Bangalore 560004, Karnataka, India
关键词
HIV-1; immunogen design; neutralizing antibody; stability; thioredoxin; V3; loop;
D O I
10.1042/BJ20060588
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
gp120 is a subunit of the envelope glycoprotein of HIV-1. The third variable loop region of gp120 (V3 loop) contains multiple immunodominant epitopes and is also functionally important for deciding cell-tropism of the virus. 447-52D is a monoclonal antibody that recognizes the conserved tip of the V3 loop in a P-turn conformation. This antibody has previously been shown to neutralize diverse strains of the virus. In an attempt to generate an immunogen competent to generate 447-5213-like antibodies, the known epitope of 447-52D was inserted at three different surface loop locations in the small, stable protein Escherichia coli Trx (thioredoxin). At one of the three locations (between residues 74 and 75), the insertion was tolerated, the resulting protein was stable and soluble, and bound 447-52D with an affinity similar to that of intact gp120. Upon immunization, the V3 peptide-inserted Trx scaffold was able to generate anti-V3 antibodies that could compete out 447-52D binding to gp120. Epitope mapping studies demonstrated that these anti-V3 antibodies recognized the same epitope as 447-52D. Although the 447-52D-type antibodies were estimated to be present at concentrations of 50-400 mu g/ml of serum, these were not able to effect neutralization of strains like JRFL and BAL but could neutralize the sensitive MN strain. The data suggest that because of the low accessibility of the V3 loop on primary isolates such as JRFL, it will be difficult to elicit a V3-specific, 447-52D-like antibody response to effectively neutralize such isolates.
引用
收藏
页码:483 / 491
页数:9
相关论文
共 53 条
[1]   Impact of epitope permutations in the antibody response of mice to a multi-epitope polypeptide of the V3 loop of human immunodeficiency virus type 1 [J].
Aguilar, A ;
Carrazana, Y ;
Duarte, CA .
BIOMOLECULAR ENGINEERING, 2001, 18 (03) :117-124
[2]   Thermodynamic characterization of monomeric and dimeric forms of CcdB (controller of cell division or death B protein) [J].
Bajaj, K ;
Chakshusmathi, G ;
Bachhawat-Sikder, K ;
Surolia, A ;
Varadarajan, R .
BIOCHEMICAL JOURNAL, 2004, 380 (02) :409-417
[3]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[4]   CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION [J].
BOUHABIB, DC ;
RODERIQUEZ, G ;
ORAVECZ, T ;
BERMAN, PW ;
LUSSO, P ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6006-6013
[5]   Solution conformation of an immunogenic peptide derived from the principal neutralizing determinant of the HIV-2 envelope glycoprotein gp125 [J].
Campbell, AP ;
Sykes, BD ;
Norrby, E ;
AssaMunt, N ;
Dyson, HJ .
FOLDING & DESIGN, 1996, 1 (02) :157-165
[6]   MASS-SPECTROMETRIC IDENTIFICATION OF A NATURALLY PROCESSED MELANOMA PEPTIDE RECOGNIZED BY CD8(+) CYTOTOXIC T-LYMPHOCYTES [J].
CASTELLI, C ;
STORKUS, WJ ;
MAEURER, MJ ;
MARTIN, DM ;
HUANG, EC ;
PRAMANIK, BN ;
NAGABHUSHAN, TL ;
PARMIANI, G ;
LOTZE, MT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :363-368
[7]   Protein stabilization by introduction of cross-strand disulfides [J].
Chakraborty, K ;
Thakurela, S ;
Prajapati, RS ;
Indu, S ;
Ali, PSS ;
Ramakrishnan, C ;
Varadarajan, R .
BIOCHEMISTRY, 2005, 44 (44) :14638-14646
[8]   Induction and characterization of neutralizing antibodies against a human immunodeficiency virus type 1 primary isolate [J].
Chen, CH ;
Jin, L ;
Zhu, CB ;
Holz-Smith, S ;
Matthews, TJ .
JOURNAL OF VIROLOGY, 2001, 75 (14) :6700-6704
[9]   IMMUNOGENICITY OF SYNTHETIC HIV-1 GP120 V3-LOOP PEPTIDE-CONJUGATE IMMUNOGENS [J].
CONLEY, AJ ;
CONARD, P ;
BONDY, S ;
DOLAN, CA ;
HANNAH, J ;
LEANZA, WJ ;
MARBURG, S ;
RIVETNA, M ;
RUSIECKI, VK ;
SUGG, EE ;
VANMIDDLESWORTH, F ;
WARNE, SA ;
ULRICH, JT ;
RUDBACH, JA ;
TOLMAN, RL ;
EMINI, EA .
VACCINE, 1994, 12 (05) :445-451
[10]   MODIP revisited: re-evaluation and refinement of an automated procedure for modeling of disulfide bonds in proteins [J].
Dani, VS ;
Ramakrishnan, C ;
Varadarajan, R .
PROTEIN ENGINEERING, 2003, 16 (03) :187-193